Page - (000205) - in Biomedical Chemistry: Current Trends and Developments

93. Ragan, C. I., I. Bard, et al. (2013). What should we do about student use of cognitive enhancers? An analysis of current evidence. Neuropharmacology, 64, 588-595. Rao, J. S., M. Kellom, et al. (2012). Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. Journal of Affective Disorders, 136(1-2), 63-71. Reinikainen, K. J., L. Paljarvi, et al. (1988). A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer’s disease. Journal of the Neurological Sciences, 84(1), 101-116. Reith, M. E., C. Xu, et al. (1997). Pharmacology and regulation of the neuronal dopamine transporter. European Journal of Pharmacology, 324(1), 1-10. Repantis, D., P. Schlattmann, et al. (2010). Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research, 62(3), 187-206. Riedel, O., J. Klotsche, et al. (2010). Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson’s disease. Journal Neurology, 257(7), 1073-1082. Rissman, R. A. and W. C. Mobley (2011). Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer’s disease. Journal of Neurochemistry, 117(4), 613-622. Robbins, T. W. and B. J. Everrit (1992). Functions of dopamine in the dorsal and ventral striatum. The Neurosciences, 4, 119-127. Roberts, E. and S. Frankel (1950). gamma-Aminobutyric acid in brain: its formation from glutamic acid. The Journal of Biological Chemistry, 187(1), 55-63. Robinson, S. R. (2001). Changes in the cellular distribution of glutamine synthetase in Alzheimer’s disease. Journal of Neuroscience Research, 66(5), 972-980. Roeper, J. (2013). Dissecting the diversity of midbrain dopamine neurons. Trends Neurosci 36(6): 336-342. Roselli, F., M. Tirard, et al. (2005). Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. The Journal of Neuroscience, 25(48), 11061-11070. Ross, C. A. and M. A. Poirier (2004). Protein aggregation and neurodegenerative disease. Nature Medicine, 10 Suppl, S10-17. Rossato, J. I., L. R. Bevilaqua, et al. (2009). Dopamine controls persistence of long-term memory storage. Science, 325(5943), 1017-1020. Rossi, D. J., T. Oshima, et al. (2000). Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature, 403(6767), 316-321. Sagne, C., S. El Mestikawy, et al. (1997). Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases. FEBS letters, 417(2), 177-183. Salter, M. W. and S. Beggs (2014). Sublime microglia: expanding roles for the guardians of the CNS. Cell, 158(1), 15-24. Samii, A., J. G. Nutt, et al. (2004). Parkinson’s disease. Lancet, 363(9423), 1783-1793. Sanchez, R. M., S. Koh, et al. (2001). Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures. The